Suda Pharmaceuticals Ltd Income
What is the Income of Suda Pharmaceuticals Ltd?
The Income of Suda Pharmaceuticals Ltd is -AUD$10.22
What is the definition of Income?
Net income available for common shareholders equals net income minus preferred dividends paid.
ttm (trailing twelve months)
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Income of companies in the Health Care sector on ASX compared to Suda Pharmaceuticals Ltd
What does Suda Pharmaceuticals Ltd do?
Suda Pharmaceuticals Ltd engages in the development of drug delivery technology in Australia, India, Europe and Korea. It offers ZolpiMist, an oro-mucosal spray formulation of zolpidem tartrate marketed under the brand name of Ambien or Stilnox, a non-benzodiazepine prescribed for the short-term treatment of insomnia. The company's product pipeline includes Sumatriptan, an oral spray formulation for the treatment of acute migraine; and anagrelide, a platelet lowering agent for use in thrombosis, which is used for the treatment of cancer. Suda Pharmaceuticals Ltd has license and supply agreement with Teva Pharmaceuticals International GmbH and Mitsubishi Tanabe Pharma Singapore for ZolpiMist oral spray; product development, licence, and supply agreement with Cann Pharmaceutical Australia Ltd for the development of novel oral spray of pharmaceutical-grade cannabinoid derivatives for the treatment of drug resistant epilepsy, melanoma, and motion sickness; and feasibility and option agreement with Zelira Therapeutics for the use of cannabinoids for a range of uses, including insomnia, autism, opioid reduction, anxiety, pain, and cancer. The company also has a feasibility study and option agreement with Laboratorios Ordesa, S.L. The company was formerly known as Suda Limited and changed its name to Suda Pharmaceuticals Ltd in November 2017. Suda Pharmaceuticals Ltd was incorporated in 1999 and is headquartered in Osborne Park, Australia.
Companies with income similar to Suda Pharmaceuticals Ltd
- BetterLife Pharma has Income of -CAD$10.26
- CE Brands has Income of -CAD$10.24
- X2M Connect has Income of -AUD$10.24
- Davidstea Inc has Income of -CAD$10.24
- Colonial Coal International has Income of -CAD$10.23
- Kiniksa Pharmaceuticals International Plc has Income of -$10.23
- Suda Pharmaceuticals Ltd has Income of -AUD$10.22
- Greenwich LifeSciences has Income of -$10.22
- Almonty Industries has Income of -CAD$10.21
- Onelife Capital Advisors has Income of -₨10.21
- Nemaura Medical Inc has Income of -$10.21
- Fission Uranium has Income of -CAD$10.20
- IntelliCentrics Global has Income of -$10.20